OVA-Human chorionic gonadotropin (HCG)

Cat:GMP-SMT-HCG
Awaiting product image
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-SMT-HCG Categories ,

For more than 100mg, click here for inquiry. >>

Product Details

Genemedi produces core diagnostic ingredients for test of Hormone disorders (pregnancy?) and related syndrome. GeneMedi offers paired anti-Human chorionic gonadotropin (HCG) antibodies (monoclonal antibody, mab) and Human chorionic gonadotropin (HCG antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Hormone disorders (pregnancy?) rapid test kit of Human chorionic gonadotropin (HCG) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.The human chorionic gonadotropin (hCG) helps to keep your pregnancy going. It also affects the development of your baby (fetus). Levels of hCG go up fast in the first 14 to 16 weeks after your last menstrual period. They are the highest around the 14th week following your last period. They then go down gradually. The amount that hCG goes up early in pregnancy can give information about your pregnancy and the health of your baby. Soon after delivery, hCG can no longer be found in your blood. More hCG is released in a multiple pregnancy, such as twins or triplets, than in a single pregnancy. Less hCG is released if the fertilized egg implants in a place other than the uterus, such as in a fallopian tube (ectopic pregnancy).

Product Description

Cat No. of Pruducts

GMP-SMT-HCG-Ag01

Product Name

BSA-Human chorionic gonadotropin (HCG)

Target

Alias of Target/Biomarker

Expression platform

Synthetic

Isotypes

Bioactivity validation

Competitive immunoassay-validated hapten-carrier conjugates BSA-& OVA-Human chorionic gonadotropin (HCG), Human chorionic gonadotropin (HCG) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in HCG level test of Hormone disorders (pregnancy?) and related syndrome evaluation.

Tag

Products description

Competitive immunoassay-validated hapten-carrier conjugates BSA-Human chorionic gonadotropin (HCG) / OVA-Human chorionic gonadotropin (HCG) is Synthetic.

Reconized/Reactive Species

Purity

High (TBD)

Application

Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.

Formulation

Lyophilized from sterile PBS, PH 7.4

Storage

Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Genemeidi Omicron Variant Products
test
Previous slide
Next slide

Cat No. of Pruducts

GMP-SMT-HCG-Ab01

Product Name

Anti-Human chorionic gonadotropin (HCG) mouse monoclonal antibody (mAb)

Target

Human chorionic gonadotropin

Alias of Target/Biomarker

Expression platform

Hybridoma

Isotypes

Bioactivity validation

Human Human chorionic gonadotropin (HCG) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in HCG level test of Hormone disorders (pregnancy ) and related syndrome evaluation.

Tag

mFc

Products description

Anti-Human chorionic gonadotropin (HCG) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.

Reconized/Reactive Species

Purity

Purity: ≥95% （SDS-PAGE）

Application

Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.

Formulation

Lyophilized from sterile PBS, PH 7.4

Storage

Store at  -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1

Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.